Cotempla XR-ODT

Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Thu, 12/27/18 - 10:17 pm
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval
Xconomy
Tue, 06/20/17 - 08:57 am
Neos Therapeutics
ADHD
FDA
Cotempla XR-ODT
FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval
Fierce Biotech
Tue, 10/20/15 - 09:44 am
FDA
Neos
Ritalin
ADHD
Cotempla XR-ODT